KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Gross Profit (2016 - 2025)

Historic Gross Profit for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to $15.9 million.

  • Pacific Biosciences Of California's Gross Profit rose 5894.64% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.3 million, marking a year-over-year increase of 673.19%. This contributed to the annual value of $37.3 million for FY2024, which is 2936.34% down from last year.
  • Per Pacific Biosciences Of California's latest filing, its Gross Profit stood at $15.9 million for Q3 2025, which was up 5894.64% from $14.7 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Gross Profit peaked at $17.9 million during Q3 2023, and registered a low of -$1.4 million during Q1 2025.
  • Its 5-year average for Gross Profit is $12.0 million, with a median of $13.5 million in 2022.
  • Over the last 5 years, Pacific Biosciences Of California's Gross Profit had its largest YoY gain of 14728.86% in 2025, and its largest YoY loss of 11215.21% in 2025.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Gross Profit stood at $16.8 million in 2021, then plummeted by 69.34% to $5.1 million in 2022, then skyrocketed by 86.21% to $9.6 million in 2023, then increased by 5.09% to $10.1 million in 2024, then surged by 58.09% to $15.9 million in 2025.
  • Its Gross Profit stands at $15.9 million for Q3 2025, versus $14.7 million for Q2 2025 and -$1.4 million for Q1 2025.